Xcout Intel
Sanara MedTech Inc. competitors & alternatives
The 12 closest competitors and alternatives to Sanara MedTech Inc. among medical devices companies — ranked by similarity to what Sanara MedTech Inc. actually does, not by market-cap band.
Subscribe to see Sanara MedTech Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Sanara MedTech Inc.
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.
Sanara MedTech Inc. at a glance
Sanara MedTech Inc. is a medical devices company headquartered in Fort Worth, United States. It is publicly listed (SMTI) with a market capitalisation of $244.1M. Xcout tracks 26 named people at Sanara MedTech Inc., including Seth Yon (President, Chief Executive Officer & Director).
Sanara MedTech Inc. leadership
- Seth YonPresident, Chief Executive Officer & Director
- Suresh V. MuppallaPresident & Chief Executive Officer of THP
- Jacob A. WaldropChief Operating Officer
- Elizabeth TaylorChief Financial Officer
- Bill FitzgeraldChief Compliance Officer
- Nina BiondaChief R&D Officer
20 more named people on record for Sanara MedTech Inc., with roles, board committees and tenure — see the full roster →
Recent Sanara MedTech Inc. news
- AcquisitionM&A communication (425)
- AcquisitionSanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - stocktitan.net
- AcquisitionM&A communication (425)
5 corporate events on record, with sources — see the full timeline →
Top 12 Sanara MedTech Inc. competitors
Ranked by semantic similarity — how close each company is to Sanara MedTech Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Device
BioWound Solutions, LLC provides advanced wound management products and dressings, including collagen technologies, antimicrobial protections, and moisture-balancing solutions. The company serves healthcare providers, clinicians, and organizations by supplying medical products designed to promote wound healing and clinical efficiency.
Medical Device & Biotechnology
RenovoDerm manufactures advanced wound care products, specifically the Phoenix Wound Matrix, which is a synthetic, bioabsorbable scaffold designed to promote tissue regeneration and healing for acute and chronic wounds and burns. The company serves medical specialists such as podiatric surgeons and wound care providers by offering solutions to improve patient healing outcomes.
Similar medical devices company
Clyra Medical Technologies, Inc. develops advanced wound management and irrigation products utilizing patent-protected oxidative chemistry. The company serves patients and healthcare providers by offering safe, non-toxic treatments designed to combat microorganisms and aid in wound healing without harming healthy tissue.
Medical Device
DEBx Medical develops and provides wound care products, specifically its flagship product Debrichem, designed to eliminate biofilm and infection in chronic and complex wounds. The treatment is used by healthcare professionals in ambulatory and hospital settings to facilitate faster wound bed preparation and healing while reducing the need for antibiotics and complex surgeries.
Similar medical devices company
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts. AMNIOBURN is also a semi-permeable protective allograft specifically developed for managing partial and full-thickness burn injuries. Its flagship product, mdHACM, is a micronized, powdered version of AMNIOFIX. These products predominantly find use in healthcare sectors like wound management, burn treatment, surgical procedures, and non-operative sports medicine. Additionally, the company supplies allografts for dental uses to other manufacturers on an original equipment manufacturer (OEM) basis. Distribution of its products primarily occurs within the United States, facilitated by its own sales teams, independent agents, and various independent distributors. MiMedx Group, Inc.'s main office is located in Marietta, Georgia.
Similar medical devices company
Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North America, Europe, the Middle East, Asia, and Latin America, with licensing agreements in place. The company leverages three distinct proprietary technology platforms. Firstly, its collagen matrix platform underpins a family of products aimed at treating a variety of chronic and infected wounds, such as diabetic, pressure, and venous ulcers, as well as donor and graft sites, traumatic injuries healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is incorporated into pre- and post-surgical and vascular access products; these are specifically engineered to provide broad-spectrum antimicrobial protection by eliminating bacteria or yeast on contact. Thirdly, a unique medical coating platform employs a proprietary photo-polymerization process to generate active grafting sites, enabling the initiation and growth of new polymer chains directly on existing medical devices. Covalon's product portfolio, branded under "Covalon," encompasses advanced wound care dressings, surgical and peri-operative solutions, and infection management tools. These offerings reach a diverse clientele, including hospitals, specialized wound and burn centers, acute and long-term care facilities, home health care agencies, and physicians' offices, via a combination of direct sales and extensive third-party distribution networks.
Similar medical devices company
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Similar medical devices company
Headquartered in San Antonio, Texas, Acelity is a medical equipment company founded in 1976 that develops customer-focused solutions to advance the science of healing and patient care. It operates globally with thousands of employees and functions as a subsidiary of 3M.
Biotechnology & Medical Devices
Molecular Matrix, Inc. is a privately held medical device and tissue regeneration company founded in 2011. Headquartered in Rancho Cordova, California, the company develops regenerative products.
Similar medical devices company
3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell therapy, advanced drug delivery systems, and surgical interventions. This Tokyo-based firm was established in 2004.
Similar medical devices company
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
Similar medical devices company
PolyNovo Limited develops and manufactures synthetic skin substitutes using its proprietary NovoSorb technology. The company provides medical products designed to support wound management and natural healing for healthcare professionals and patients.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Sanara MedTech Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Sanara MedTech Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →